Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 130
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
7/1/1990
1.
Phase II/III Combination Chemotherapy with FAME (5-FU/ADR/MeCCNU) vs FAP (5-FU/ADR/CACP) vs FAME Alternating with TZT vs 5-FU Alone for Advanced Gastric Carcinoma (Summary Last Modified 07/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Completed
18 and over
NCI
NCCTG-834151
MAYO-834151, NCCTG-83-41-51
2.
Phase II/III Chemotherapy with Intraperitoneal CDDP in Patients with Ovarian Carcinoma Limited to the Peritoneal Cavity
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
no age specified
UCLA-81021523
NCI-V83-0303
3.
Phase II/III Randomized Comparison of PF (CACP/5-FU) vs MVPF (MITO/VCR/CACP/5-FU) in Advanced Large Bowel Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
no age specified
NCI
EST-1285
EST-1285
Last Modified:
7/5/2007
4.
Phase III Randomized Comparison of Combination Chemotherapy with CBDCA/CTX vs CACP/CTX in Patients with Stage III/IV Ovarian Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase I
Treatment
Completed
18 and over
NCI
SWOG-8412
SWOG-8412
5.
Phase III Preoperative Radiotherapy plus MTX/BLEO/CACP vs Conventional Therapy for Stage III-IV and Recurrent Intraoral Squamous Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
85 and under
NCI-D78-005-053
CCOG-784
6.
Phase III Preoperative Chemotherapy with CACP/MTX/BLEO/VCR plus Postoperative Radiotherapy for Untreated Stage III-IV Head & Neck Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
NCI-D78-035-102
7.
Phase III Combination Chemotherapy with VBL/BLEO and Sequential Chemotherapy with CACP for Advanced Testicular and Extragonadal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
MDAR-175
8.
Phase III VAM (VCR/ADR/MTX) vs ADR for Thyroid Carcinoma Not Amenable to Other Therapy Modalities
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
NCI-D79-026-161
RPMI-997906
9.
Phase III Chemotherapy with ADR/CTX/CACP Followed by Orchiectomy or Hormone Therapy with DES for Chemotherapy Failures with Metastatic Prostatic Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
under 70
NCI-78-C-56
NCI-NMOB-814
Last Modified:
4/1/1997
10.
Phase III Pre- and Postoperative Combination Chemotherapy Including High-Dose MTX in Children with Previously Untreated Nonmetastatic Osteogenic Sarcoma of an Extremity (Summary Last Modified 04/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
2 to 21
NCI
CCG-782
CCG-782
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute